A randomized, comparative study of dual therapy (doxycycline-rifampin) versus triple therapy (doxycycline-rifampin-levofloxacin) for treating acute/subacute brucellosis.

Braz J Infect Dis · 2016 · PMC9425512 · PMID 27086734

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Regarding the safety profile of the used regimens, the rate of adverse effects was higher in group-B (20.4%) compared to group-A (11.3%), although this difference did not reach statistical significance ( p -value 0.059).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.